Piver Ms

569 total citations
43 papers, 440 citations indexed

About

Piver Ms is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Piver Ms has authored 43 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Reproductive Medicine, 13 papers in Obstetrics and Gynecology and 7 papers in Surgery. Recurrent topics in Piver Ms's work include Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Reproductive Biology and Fertility (3 papers). Piver Ms is often cited by papers focused on Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Reproductive Biology and Fertility (3 papers). Piver Ms collaborates with scholars based in United States. Piver Ms's co-authors include Marie Gamarra, Peter Greenwald, Yuiko Tsukada, Yuichiro Tsukada, John R. Lurain, John F. Barlow, Y. Tsukada, J. P. Whiteley, Malaya Bhattacharya and John H. Malfetano and has published in prestigious journals such as European Journal of Gynaecological Oncology, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Piver Ms

42 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piver Ms United States	12	222	131	130	115	72	43	440
J. Mould United Kingdom	14	168 0.8×	217 1.7×	118 0.9×	183 1.6×	58 0.8×	27	445
Decker Dg United States	12	375 1.7×	191 1.5×	136 1.0×	154 1.3×	84 1.2×	22	598
Elizabeth Mussey United States	13	360 1.6×	230 1.8×	119 0.9×	143 1.2×	85 1.2×	25	637
Joan E. Woodward United States	11	188 0.8×	230 1.8×	112 0.9×	112 1.0×	54 0.8×	12	454
Tapio Kuoppala Finland	15	304 1.4×	266 2.0×	109 0.8×	135 1.2×	37 0.5×	35	630
Malkasian Gd United States	16	495 2.2×	228 1.7×	121 0.9×	227 2.0×	50 0.7×	33	739
Shashikant B. Lele United States	13	531 2.4×	322 2.5×	118 0.9×	255 2.2×	123 1.7×	29	699
William J. Hoskins United States	8	300 1.4×	294 2.2×	89 0.7×	249 2.2×	171 2.4×	8	565
J B Truc France	11	454 2.0×	261 2.0×	99 0.8×	202 1.8×	39 0.5×	13	701
David P. Schammel United States	14	324 1.5×	226 1.7×	122 0.9×	70 0.6×	76 1.1×	34	643

Countries citing papers authored by Piver Ms

Since Specialization

Citations

This map shows the geographic impact of Piver Ms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piver Ms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piver Ms more than expected).

Fields of papers citing papers by Piver Ms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piver Ms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piver Ms. The network helps show where Piver Ms may publish in the future.

Co-authorship network of co-authors of Piver Ms

This figure shows the co-authorship network connecting the top 25 collaborators of Piver Ms. A scholar is included among the top collaborators of Piver Ms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piver Ms. Piver Ms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ms, Piver. (2006). Treatment of ovarian cancer at the crossroads: 50 years after single-agent melphalan chemotherapy.. PubMed. 20(10). 1156, 1158–1156, 1158. 25 indexed citations

Ms, Piver. (2000). The Gilda Radner Familial Ovarian Cancer Registry 1981-2000.. PubMed. 21(4). 325–33. 5 indexed citations

Ms, Piver, et al.. (1998). Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer.. PubMed. 19(1). 5–10. 3 indexed citations

Ms, Piver, et al.. (1994). Lack of activity of 5-fluorouracil plus mitomycin-C as salvage therapy in cisplatin-resistant epithelial ovarian cancer: results of a phase II trial.. PubMed. 15(3). 165–9. 2 indexed citations

Ms, Piver, et al.. (1992). Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park.. European Journal of Gynaecological Oncology. 13(2). 131–7. 4 indexed citations

Ms, Piver, et al.. (1989). Patient-controlled analgesia in gynecologic oncology. A comparative analysis.. PubMed. 34(9). 651–4. 2 indexed citations

Fanning, James, et al.. (1989). Pathologic complete response of advanced ovarian mixed mesodermal tumor to cisplatin, adriamycin and dacarbazine: a case report.. PubMed. 10(6). 365–7. 2 indexed citations

Ms, Piver. (1988). Progesterone therapy for malignant peritoneal cytology surgical stage I endometrial adenocarcinoma.. PubMed. 15(2 Suppl 1). 50–2. 7 indexed citations

Ms, Piver, et al.. (1988). Malignant peritoneal cytology in stage I endometrial adenocarcinoma: the effect of progesterone therapy (a preliminary report).. PubMed. 9(3). 187–90. 2 indexed citations

10.

Ms, Piver, et al.. (1984). Familial Ovarian Cancer Registry.. PubMed. 64(2). 195–9. 42 indexed citations

11.

Ms, Piver, et al.. (1980). Weekly cis-diamminedichloroplatinum(II): active third-line chemotherapy in ovarian carcinoma--a preliminary report.. PubMed. 64(12). 1379–82. 7 indexed citations

12.

Ms, Piver, et al.. (1980). Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.. PubMed. 56(3). 370–2. 6 indexed citations

13.

Ms, Piver, et al.. (1977). Single agent vs combination chemotherapy in the treatment of ovarian cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 49(5). 609–11. 30 indexed citations

14.

Ms, Piver. (1977). The value of pretherapy para-aortic lymphadenectomy for carcinoma of the cervix uteri.. PubMed. 145(1). 17–8. 19 indexed citations

15.

Ms, Piver, et al.. (1976). Preoperative and intraoperative evaluation in ovarian malignancy.. PubMed. 48(3). 312–5. 26 indexed citations

16.

Ms, Piver, et al.. (1976). Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.. PubMed. 60(5). 527–33. 9 indexed citations

17.

Ms, Piver, et al.. (1974). Para-aortic lymphadenectomy in staging patients with advanced local cervical cancer.. PubMed. 43(4). 544–8. 33 indexed citations

18.

Ms, Piver, et al.. (1971). Monilia septicemia associated with hyperalimentation.. PubMed. 38(6). 896–8. 8 indexed citations

19.

Ms, Piver. (1967). Fetal outcome in nondiabetic glucosuria in pregnancy.. PubMed. 30(4). 576–9. 1 indexed citations

20.

Ms, Piver, et al.. (1966). Effect of an intrauterine contraceptive device upon cervical and endometrial exfoliative cytology.. PubMed. 28(4). 528–31. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact